Approvals/TGA/BEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle

Approved

STANDARD

BEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: Dec 9, 2025
Approval ID: f1e3608ec1841de3
Company: GlaxoSmithKline Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: f1e3608ec1841de3
Product Name: BEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle
Artg Id: 190718
Artg Name: BEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2013-08-14
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/4139b7eaa3057cc98b3e5f2f8914d527.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/4945443148588198a74ba8e839bf7ac7.pdf

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

f1e3608ec1841de3

Type

Standard

Back to TGA Approvals